Shenzhen Noposion Crop Science Co., Ltd. (SHE:002215)
China · Delayed Price · Currency is CNY 9.58
+0.87 (9.99%)
Jun 12, 2026, 3:04 PM CST
SHE:002215 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 6,291 | 5,761 | 5,265 | 4,103 | 4,250 | 4,477 |
Other Revenue | 21.36 | 21.36 | 23.51 | 16.45 | 15.08 | 23.87 |
| 6,312 | 5,783 | 5,288 | 4,120 | 4,265 | 4,501 | |
Revenue Growth (YoY) | 13.48% | 9.35% | 28.37% | -3.41% | -5.23% | 8.94% |
Cost of Revenue | 4,031 | 3,635 | 3,327 | 2,916 | 3,121 | 3,297 |
Gross Profit | 2,281 | 2,148 | 1,961 | 1,203 | 1,144 | 1,203 |
Selling, General & Admin | 1,005 | 1,000 | 976.4 | 684.85 | 643.71 | 703.1 |
Research & Development | 148.41 | 142.6 | 142.95 | 118.9 | 125.62 | 107.38 |
Other Operating Expenses | 19.2 | 8.16 | 7.79 | -2.88 | 16 | 12.89 |
Operating Expenses | 1,261 | 1,239 | 1,233 | 890.63 | 835.49 | 861.85 |
Operating Income | 1,021 | 908.71 | 728.1 | 312.61 | 308.7 | 341.63 |
Interest Expense | -93.65 | -88.7 | -103.08 | -97.56 | -96.85 | -68.06 |
Interest & Investment Income | 66.95 | 63.67 | 69.63 | 51.05 | 81.57 | 47.04 |
Currency Exchange Gain (Loss) | 0.58 | 0.58 | 2.48 | 1.12 | 0.01 | -1.09 |
Other Non Operating Income (Expenses) | -38.32 | -41.46 | -44.62 | -3.05 | -11.37 | -10.02 |
EBT Excluding Unusual Items | 956.14 | 842.8 | 652.51 | 264.17 | 282.06 | 309.5 |
Impairment of Goodwill | -11.07 | -11.07 | -8.1 | -9.21 | -14.48 | -10.41 |
Gain (Loss) on Sale of Investments | -76.08 | -76.08 | -65.5 | -13.4 | - | -7.11 |
Gain (Loss) on Sale of Assets | 16.85 | 18.05 | -16.73 | -0.46 | 28.81 | 8.18 |
Asset Writedown | -142.48 | -142.48 | -29.3 | -22.57 | -9.21 | -12.03 |
Other Unusual Items | 40.47 | 35.66 | 37.41 | -1.53 | 57.48 | 54.87 |
Pretax Income | 783.83 | 666.88 | 570.3 | 217 | 344.66 | 343.01 |
Income Tax Expense | 22.74 | 29.35 | 9.2 | 12.43 | 17.48 | 45.74 |
Earnings From Continuing Operations | 761.09 | 637.53 | 561.1 | 204.57 | 327.18 | 297.26 |
Minority Interest in Earnings | 14.96 | 12.88 | 23.49 | 31.06 | 1.26 | 8.07 |
Net Income | 776.05 | 650.42 | 584.59 | 235.63 | 328.44 | 305.33 |
Net Income to Common | 776.05 | 650.42 | 584.59 | 235.63 | 328.44 | 305.33 |
Net Income Growth | 2.49% | 11.26% | 148.10% | -28.26% | 7.57% | 82.93% |
Shares Outstanding (Basic) | 986 | 984 | 996 | 978 | 977 | 903 |
Shares Outstanding (Diluted) | 1,013 | 1,014 | 1,020 | 1,003 | 996 | 919 |
Shares Change (YoY) | -0.58% | -0.59% | 1.75% | 0.62% | 8.38% | 0.91% |
EPS (Basic) | 0.79 | 0.66 | 0.59 | 0.24 | 0.34 | 0.34 |
EPS (Diluted) | 0.77 | 0.64 | 0.57 | 0.23 | 0.33 | 0.33 |
EPS Growth | 3.09% | 11.92% | 143.83% | -28.70% | -0.75% | 81.28% |
Free Cash Flow | 185.05 | 239.67 | 118.08 | -344.92 | -730.27 | -84.68 |
Free Cash Flow Per Share | 0.18 | 0.24 | 0.12 | -0.34 | -0.73 | -0.09 |
Dividend Per Share | 0.300 | 0.300 | 0.350 | 0.150 | 0.150 | 0.200 |
Dividend Growth | -14.29% | -14.29% | 133.33% | - | -25.00% | 100.00% |
Gross Margin | 36.14% | 37.15% | 37.08% | 29.21% | 26.83% | 26.74% |
Operating Margin | 16.17% | 15.72% | 13.77% | 7.59% | 7.24% | 7.59% |
Profit Margin | 12.29% | 11.25% | 11.05% | 5.72% | 7.70% | 6.78% |
Free Cash Flow Margin | 2.93% | 4.15% | 2.23% | -8.37% | -17.12% | -1.88% |
EBITDA | 1,527 | 1,389 | 1,101 | 532.93 | 439.55 | 458.02 |
EBITDA Margin | 24.20% | 24.02% | 20.82% | 12.94% | 10.31% | 10.18% |
D&A For EBITDA | 506.91 | 480.13 | 373.03 | 220.32 | 130.85 | 116.4 |
EBIT | 1,021 | 908.71 | 728.1 | 312.61 | 308.7 | 341.63 |
EBIT Margin | 16.17% | 15.71% | 13.77% | 7.59% | 7.24% | 7.59% |
Effective Tax Rate | 2.90% | 4.40% | 1.61% | 5.73% | 5.07% | 13.34% |
Revenue as Reported | 6,312 | 5,783 | 5,288 | - | 4,265 | 4,501 |
Advertising Expenses | - | 60.67 | 65.04 | 65.56 | - | - |